What is Radiopharm Theranostics Ltd - ADR Annual Revenue?

Radiopharm Theranostics Ltd - ADR Annual Revenue rose 2.35%, in the last year to $0.3 M. Its sector's average revenue growth for the last fiscal year was 8.54%.

What is Radiopharm Theranostics Ltd - ADR Annual Net Profit?

Radiopharm Theranostics Ltd - ADR Annual Net Profit fell 38.54% in the last year to $47.95 M. Its sector's average net profit growth for the last fiscal year was 3.28%.

What is Radiopharm Theranostics Ltd - ADR Return on Equity(ROE)?

Radiopharm Theranostics Ltd - ADR Return on Equity(ROE) for the last financial year was -132.26%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Radiopharm Theranostics Ltd - ADR Interest Coverage Ratio?

Radiopharm Theranostics Ltd - ADR Interest Coverage Ratio is -73.43, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Radiopharm Theranostics Ltd - ADR Institutional Holding?

Radiopharm Theranostics Ltd - ADR Institutional Holding increased by 5.6% in the last quarter to 5.6.

How is the Radiopharm Theranostics Ltd - ADR today?

The Radiopharm Theranostics Ltd - ADR today is trading in the green, up by 0.99% at 4.09.

How has Radiopharm Theranostics Ltd - ADR performed historically?

The Radiopharm Theranostics Ltd - ADR is currently trading up 0.99% on an intraday basis in the past week the index fell None%. The index has been down None% in the past quarter and fell None% in the past year. You can view this in the overview section.

Radiopharm Theranostics Ltd - ADR XNAS: RADX

Radiopharm Theranostics Ltd - ADR Live Share Price Today, Share Analysis and Chart

Name: Radiopharm Theranostics Ltd - ADR: Is Infosys Ltd. worth buying?
Item: Radiopharm Theranostics Ltd - ADR
Rating: 0.5333335
Author: Trendlyne DVM scores

Download real time

4.09 0.04 (0.99%)

New 52W High today

2,138 XNAS Volume

XNAS 24 Apr, 2025 4:00 PM (EDT)

Radiopharm Theranostics Lt... Key Metrics

My Metrics

Select

Market Capitalization Low in industry Unavailable in chosen country	31.8
Price to Book Below industry Median Unavailable in chosen country	1.5
Institutional holding current Qtr % Low in industry Unavailable in chosen country	5.6
Piotroski Score Low in industry Unavailable in chosen country	1
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-132.3
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-65.2

All financials are in AUD Million and price data in USD

Not Eligible

Expensive Valuation

10.7 / 100

No Score Avaliable

- / 100

1Yr Price target downside is -96%

1 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Not enough data available

Radiopharm Theranostics Lt... Stock Price Analysis

Day Price Range

1.0% 1 Day return

4.1 (LTP)

44.3

LowHigh

View full Share Price History

Radiopharm Theranostics Lt... Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Inline

Radiopharm Theranostics Ltd - ADR's Revenue was higher than average estimate 1 time in past 2 years

Consensus Recommendation

1 ANALYST Recommendations

STRONG BUY

The consensus recommendation from 1 analyst for Radiopharm Theranostics Ltd - ADR is STRONG BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Radiopharm Theranostics Lt... Stock Analysis

Radiopharm Theranostics Lt... stock analysis with key metrics, changes, and trends.

Radiopharm Theranostics Lt... Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$0.3 M	2.35%	positive	Annual Revenue rose 2.35%, in the last year to $0.3 M. Its sector's average revenue growth for the last fiscal year was 8.54%.
Annual Net Profit	$47.95 M	38.54%	negative	Annual Net Profit fell 38.54% in the last year to $47.95 M. Its sector's average net profit growth for the last fiscal year was 3.28%.
Return on Equity(ROE)	-132.26 %	-132.26%	negative	Return on Equity(ROE) for the last financial year was -132.26%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Interest Coverage Ratio	-73.43	-	negative	Interest Coverage Ratio is -73.43, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).
Institutional Holding	5.60 %	5.6%	positive	Institutional Holding increased by 5.6% in the last quarter to 5.6.

VIEW LESS

Loading data..

Radiopharm Theranostics Ltd - ADR - Company Profile

What does Radiopharm Theranostics Ltd - ADR do?

Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.

Gross Remuneration

2024

Gross Remuneration

Year

Radiopharm Theranostics Ltd - ADR Live Share Price Today, Share Analysis and Chart

New 52W High today

Radiopharm Theranostics Lt... Key Metrics

Market Capitalization

Price to Book

Institutional holding current Qtr %

Piotroski Score

ROE Annual %

RoA Annual %

Market Capitalization

Price to Book

Institutional holding current Qtr %

Piotroski Score

ROE Annual %

RoA Annual %

Check Before You Buy

Check P/E Buy Sell Zone

Radiopharm Theranostics Lt... Stock Price Analysis

Day Price Range

Radiopharm Theranostics Lt... Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Radiopharm Theranostics Ltd - ADR's Revenue was higher than average estimate 1 time in past 2 years

Consensus Recommendation

The consensus recommendation from 1 analyst for Radiopharm Theranostics Ltd - ADR is STRONG BUY

Radiopharm Theranostics Lt... Stock Analysis

Radiopharm Theranostics Lt... stock analysis with key metrics, changes, and trends.

Annual Revenue rose 2.35%, in the last year to $0.3 M. Its sector's average revenue growth for the last fiscal year was 8.54%.

Annual Net Profit fell 38.54% in the last year to $47.95 M. Its sector's average net profit growth for the last fiscal year was 3.28%.

Return on Equity(ROE) for the last financial year was -132.26%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Interest Coverage Ratio is -73.43, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding increased by 5.6% in the last quarter to 5.6.

Radiopharm Theranostics Ltd - ADR - Company Profile

What does Radiopharm Theranostics Ltd - ADR do?

Radiopharm Theranostics Ltd - ADR Management structure

Dr. Thomas H. Tulip

Chief Business Officer

Mr. Phillip A. Hains

Director, Chief Financial Officer and Company Secretary

Dr. Dimitris Voliotis, M.D.

Chief Medical Officer

Mr. Riccardo Canevari

Chief Executive Officer and Managing Director

Radiopharm Theranostics Ltd - ADR Board of directors

Mr. Paul E Hopper

Executive Chairman of the Board

Mr. Phillip A. Hains

Director, Chief Financial Officer and Company Secr

Dr. Leila Alland, M.D.

Director

Mr. Noel Donnelly, M.B.A.

Independent Director

Ms. Hester Larkin

Independent Director

Mr. Ian Turner

Director

Radiopharm Theranostics Ltd - ADR FAQ

How is Radiopharm Theranostics Ltd - ADR today?

Radiopharm Theranostics Ltd - ADR today is trading in the green, and is up by 0.99% at 4.09.

How has Radiopharm Theranostics Ltd - ADR performed historically?

Radiopharm Theranostics Ltd - ADR is currently trading up 0.99% on an intraday basis. In the past week the stock fell None%. stock has been down None% in the past quarter and fell None% in the past year. You can view this in the overview section.